Drug Based on Institute for Psychedelics and Neurotherapeutics Research to Be Tested in Patients by College of Letters and Science January 07, 2025 News & Noteworthy Science & Technology Delix Therapeutics recently announced that the first neuroplastogen drug based on UC Davis Institute for Psychedelics and Neurotherapeutics (IPN) research will be tested in patients with major depressive disorder.
